The Annual General Meeting in PhotoCure ASA took place on 3 April 2003. The General Meeting approved the Directors' Report and the Annual Accounts, as well as the Board of Directors' proposed settlement of the deficit of 2002.
Åse Aulie Michelet and Tharald Brøvig have resigned from the Board of Directors. Birgit Stattin Norinder is elected as a new member of the Board. She is a trained pharmacist and is 54 years of age. She has held management positions in the international pharmaceutical companies Pharmacia & Upjohn, Glaxo Group Research, Astra and Pfizer. She has also served as CEO of Prolifix Ltd., a biotech company with a focus on oncology.
The new Board of Directors of PhotoCure ASA now consists of:
Erik Engebretsen, chairman
Per-Olof Mårtensson, deputy chairman
Halvor Bjerke
Lars Lindegren
Birgit Stattin Norinder
In accordance with the proposals of the Board of Directors, the General Meeting also resolved to grant authority to the Board to increase the share capital and to acquire own shares.